The UK National Institute for Health and Care Excellence (NICE) recommends a glycaemic target of HbA 1c 53 mmol/mol (7.0%) for people with T2D on medications associated with hypoglycaemia, and a target of HbA 1c 48 mmol/mol (6.5%) otherwise [5, 6]
BPC is commonly expanded as Body Protection Compound, while 157 identifies the peptide within the research series in which it was described
No, weight loss injections such as semaglutide and liraglutide are not appropriate for people with type 1 diabetes
Retatrutide Side Effects Guide Retatrutide side effects from Phase 2 trial data
Establishing a bowel routine can be helpful
I hold active professional licenses in BC (CHPBC), Alberta (CDA), and Ontario (CDO), allowing me to provide regulated Medical Nutrition Therapy across these provinces